Concepedia

Thomas Arron Illingworth

TA

Statistics

Publications

2

Citations

24

H-Index

2

Active since

2019

Affiliations

University of Derby(Current)

Thomas Arron Illingworth is an author at University of Derby specializing in signal transduction, cancer biology, and receptor pharmacology.

ORCID

Publications per year

2019–2022

2

Publications

2

The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA

Peter J. G. Cussell, Michael S. Howe, Thomas Arron Illingworth et al. · PLoS ONE · 2019 · 13 citations · Full text

, , +9

Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques—an in silico study

M I Rock, George D. Zouganelis, Ana Flávia Belchior de Andrade et al. · Journal of Integrative Neuroscience · 2022 · 11 citations · Full text

, , +17

1–2 of 2